Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.

Saved in:
Bibliographic Details
Title: Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
Authors: Compagnucci A; INSERM SC10-US19, Essais Thérapeutiques et Maladies Infectieuses, Villejuif, France., Chan MK; MRC Clinical Trials Unit at UCL, London, UK., Saïdi Y; INSERM SC10-US19, Essais Thérapeutiques et Maladies Infectieuses, Villejuif, France., Cressey TR; AMS-CMU & IRD Research Collaboration, Faculty of Associated Medical Sciences (AMS), Chiang Mai University, Thailand., Bamford A; MRC Clinical Trials Unit at UCL, London, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.; UCL Great Ormond Street Institute of Child Health, London, UK., Riault Y; INSERM SC10-US19, Essais Thérapeutiques et Maladies Infectieuses, Villejuif, France., Coelho A; INSERM SC10-US19, Essais Thérapeutiques et Maladies Infectieuses, Villejuif, France., Nolan A; MRC Clinical Trials Unit at UCL, London, UK., Chalermpantmetagul S; AMS-CMU & IRD Research Collaboration, Faculty of Associated Medical Sciences (AMS), Chiang Mai University, Thailand., Morkunaite G; Penta Foundation, Padova, Italy., Amuge P; Baylor College of Medicine Children's Foundation, Kampala, Uganda., Musiime V; Joint Clinical Research Centre, Lubowa, Kampala, Uganda.; Makerere University, Department of Paediatrics and Child Health, Kampala, Uganda., Violari A; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Cotton M; FAMCRU, Department of Paediatrics & Child Health, Family Center for Research with Ubuntu, Stellenbosch University, South Africa., Kekitiinwa AR; Baylor College of Medicine Children's Foundation, Kampala, Uganda., Kaudha E; Joint Clinical Research Centre, Lubowa, Kampala, Uganda., Groenewald M; FAMCRU, Department of Paediatrics & Child Health, Family Center for Research with Ubuntu, Stellenbosch University, South Africa., Liberty AA; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Kanjanavanit S; Nakornping Hospital, Chiang Mai, Thailand., Volokha A; Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine., Bologna R; Hospital Garrahan, Buenos Aires, Argentina., Pavia Ruz N; Clínica para niños con VIH, UNAM/HGM; Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico., Prieto Tato L; Hospital Universitario 12 de Octubre, Madrid, Spain., Paioni P; Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich, Switzerland., Marques L; Centro Materno-Infantil do Norte, CHU Porto, Porto, Portugal., Reliquet V; Infectious Diseases Department, CHU Hôtel Dieu and INSERM UIC 1413, Nantes University, Nantes, France., Niehues T; Centre for Child Health and Adolescence, Helios Klinikum Krefeld, Academic Hospital, RWTH Aachen, Krefeld, Germany., Welch SB; Department of Paediatrics, Heartlands Hospital, University Hospitals Birmingham, Birmingham, UK., Ford D; MRC Clinical Trials Unit at UCL, London, UK., Giaquinto C; Department of Women's and Children's Health, University of Padova, Padova, Italy., Gibb DM; MRC Clinical Trials Unit at UCL, London, UK., Babiker A; MRC Clinical Trials Unit at UCL, London, UK., Ramos Amador JT; Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC); Fundación para la Investigación Biomédica HCSC; Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain.
Corporate Authors: SMILE-PENTA17-ANRS 152 Trial Group
Source: EClinicalMedicine [EClinicalMedicine] 2023 Jun 02; Vol. 60, pp. 102025. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5370
DOI:10.1016/j.eclinm.2023.102025